36
Participants
Start Date
July 31, 2020
Primary Completion Date
September 1, 2028
Study Completion Date
September 1, 2028
Paclitaxel
"1. Patients will receive treatment on Day 1 and 8 starting with cycle 2.~2. Paclitaxel (80 mg) will be administered IV on days 1 and 8 starting with cycle 2 (every 21 days).~3. Drug - Paclitaxel - 80mg IV"
Olaparib
"1. Olaparib will be taken by mouth daily for 3 weeks (every 21 days).~2. Drug - 100 mg or 300mg"
Pembrolizumab
"1. Patients will receive treatment every 21 days.~2. Pembrolizumab (200 mg) will be administered IV on day 1 (every 21 days).~3. Drug - 200mg IV"
Sidney Kimmel Comprehensive Cancer Center, Baltimore
Merck Sharp & Dohme LLC
INDUSTRY
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
OTHER